While the recent market dip has created bargains, some stocks have sufficiently lagged the market in the past year to warrant that title regardless of what's transpired in 2025. Among them are CRISPR ...

Dividend-paying stocks are a traditional defensive play, while healthcare faces fewer trade and economic headwinds than most ...

According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Jimmy Investor. In this article, we will summarize ...

Recursion Pharmaceuticals appointed former FDA principal deputy commissioner Namandjé Bumpus, PhD, and Elaine Sun, the COO and CFO of Mammoth Biosciences, to its board of directors. CAMP4 Therapeutics ...

Imagine yourself as a passive income investor looking for a medical stock with significant share growth potential. Wall ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

March 11 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday ... Trump has been piling pressure on drugmakers since taking office to move medicine production to the U.S., and has threatened ...

Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease ...

Merck Foundation marks World Cancer Day with African First Ladies by providing 194 scholarships of Oncology Trai ...